Leapfrogging into the futureBMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d2990 (Published 13 May 2011) Cite this as: BMJ 2011;342:d2990
- Jane Parry
- 1Hong Kong
The completion of the human genome project in 2003 was hailed at the time as a scientific breakthrough that would revolutionise medicine. Eight years on, although genomics undoubtedly has revolutionary potential, there has been little consensus on the likely pace of change, and even less on the implications of genomics for public health.
The promise of personalised medical treatment, the potential to screen for inherited diseases, the explosion in availability of direct-to-consumer genetic testing services, are all interesting issues for public health practitioners. But, says Ron Zimmern, chairman of the PHG Foundation (Foundation for Genomics and Population Health), the real question is not how genomics will be absorbed into the public health universe, rather it is how public health will need to change in the era of genomics.
“There is, as I see it, a crisis in public health in that it is too much dominated by social …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial